As the impact of hepatic fat accumulation per se on CKD is still a matter of debate, we aim to investigate the influence of PNPLA3, TM6SF2, MBOAT7 and GCKR genetic variants on renal function in a large population of adult NAFLD patients. This evidence concerns the gene GCKR and metabolic dysfunction-associated steatotic liver disease.